MetLife Investment Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$954K Buy
2023
Q1
$540K Hold
2022
Q4
$588K Buy
2022
Q3
$323K Hold
2022
Q2
$247K Buy
2022
Q1
$181K Buy
2021
Q4
$154K Buy